Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1953 1
1954 1
1955 2
1956 5
1957 1
1958 1
1959 1
1960 2
1961 6
1962 5
1963 5
1964 6
1965 9
1966 13
1967 19
1968 16
1969 22
1970 13
1971 10
1972 14
1973 11
1974 5
1975 5
1976 3
1977 6
1978 7
1979 10
1980 10
1981 10
1982 9
1983 10
1984 7
1985 16
1986 11
1987 18
1988 14
1989 26
1990 20
1991 29
1992 16
1993 23
1994 27
1995 22
1996 18
1997 26
1998 28
1999 59
2000 48
2001 53
2002 44
2003 52
2004 45
2005 54
2006 55
2007 59
2008 49
2009 81
2010 69
2011 93
2012 109
2013 107
2014 103
2015 99
2016 119
2017 123
2018 110
2019 144
2020 126
2021 136
2022 127
2023 155
2024 161
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,632 results

Results by year

Filters applied: . Clear all
Page 1
Sedation outcomes for remimazolam, a new benzodiazepine.
Oka S, Satomi H, Sekino R, Taguchi K, Kajiwara M, Oi Y, Kobayashi R. Oka S, et al. J Oral Sci. 2021 Jun 29;63(3):209-211. doi: 10.2334/josnusd.21-0051. Epub 2021 Jun 7. J Oral Sci. 2021. PMID: 34092775 Free article. Review.
DiI labeling experiment.
Morise J, Oka S. Morise J, et al. Among authors: oka s. 2021 Sep 7 [updated 2022 Mar 14]. In: Nishihara S, Angata K, Aoki-Kinoshita KF, Hirabayashi J, editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021–. 2021 Sep 7 [updated 2022 Mar 14]. In: Nishihara S, Angata K, Aoki-Kinoshita KF, Hirabayashi J, editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021–. PMID: 37590596 Free Books & Documents. Review. No abstract available.
Glycerophosphate/Acylglycerophosphate acyltransferases.
Yamashita A, Hayashi Y, Matsumoto N, Nemoto-Sasaki Y, Oka S, Tanikawa T, Sugiura T. Yamashita A, et al. Among authors: oka s. Biology (Basel). 2014 Nov 19;3(4):801-30. doi: 10.3390/biology3040801. Biology (Basel). 2014. PMID: 25415055 Free PMC article. Review.
Population-level Metagenomics Uncovers Distinct Effects of Multiple Medications on the Human Gut Microbiome.
Nagata N, Nishijima S, Miyoshi-Akiyama T, Kojima Y, Kimura M, Aoki R, Ohsugi M, Ueki K, Miki K, Iwata E, Hayakawa K, Ohmagari N, Oka S, Mizokami M, Itoi T, Kawai T, Uemura N, Hattori M. Nagata N, et al. Among authors: oka s. Gastroenterology. 2022 Oct;163(4):1038-1052. doi: 10.1053/j.gastro.2022.06.070. Epub 2022 Jul 2. Gastroenterology. 2022. PMID: 35788347 Free article.
Combination of Amoxicillin 3000 mg and Probenecid Versus 1500 mg Amoxicillin Monotherapy for Treating Syphilis in Patients With Human Immunodeficiency Virus: An Open-Label, Randomized, Controlled, Non-Inferiority Trial.
Ando N, Mizushima D, Omata K, Nemoto T, Inamura N, Hiramoto S, Takano M, Aoki T, Watanabe K, Uemura H, Shiojiri D, Yanagawa Y, Tanuma J, Teruya K, Kikuchi Y, Gatanaga H, Oka S. Ando N, et al. Among authors: oka s. Clin Infect Dis. 2023 Sep 11;77(5):779-787. doi: 10.1093/cid/ciad278. Clin Infect Dis. 2023. PMID: 37157863 Clinical Trial.
Nomogram as a novel predictive tool for lymph node metastasis in T1 colorectal cancer treated with endoscopic resection: a nationwide, multicenter study.
Kajiwara Y, Oka S, Tanaka S, Nakamura T, Saito S, Fukunaga Y, Takamatsu M, Kawachi H, Hotta K, Ikematsu H, Kojima M, Saito Y, Yamada M, Kanemitsu Y, Sekine S, Nagata S, Yamada K, Kobayashi N, Ishihara S, Saitoh Y, Matsuda K, Togashi K, Komori K, Ishiguro M, Kuwai T, Okuyama T, Ohuchi A, Ohnuma S, Sakamoto K, Sugai T, Katsumata K, Matsushita HO, Yamano HO, Eda H, Uraoka T, Akimoto N, Kobayashi H, Ajioka Y, Sugihara K, Ueno H. Kajiwara Y, et al. Among authors: oka s. Gastrointest Endosc. 2023 Jun;97(6):1119-1128.e5. doi: 10.1016/j.gie.2023.01.022. Epub 2023 Jan 18. Gastrointest Endosc. 2023. PMID: 36669574 Free article.
Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study.
Orkin C, Oka S, Philibert P, Brinson C, Bassa A, Gusev D, Degen O, García JG, Morell EB, Tan DHS, D'Amico R, Dorey D, Griffith S, Thiagarajah S, St Clair M, Van Solingen-Ristea R, Crauwels H, Ford SL, Patel P, Chounta V, Vanveggel S, Cutrell A, Van Eygen V, Vandermeulen K, Margolis DA, Smith KY, Spreen WR. Orkin C, et al. Among authors: oka s. Lancet HIV. 2021 Apr;8(4):e185-e196. doi: 10.1016/S2352-3018(20)30340-4. Lancet HIV. 2021. PMID: 33794181 Clinical Trial.
2,632 results